Cargando…
Integrative Bioinformatics Analysis Reveals CHEK1 and UBE2C as Luminal A Breast Cancer Subtype Biomarkers
In light of the limited number of targetable oncogenic drivers in breast cancer (BRCA), it is important to identify effective and druggable gene targets for the treatment of this devastating disease. Herein, the GSE102484 dataset containing expression profiling data from 683 BRCA patients was re-ana...
Autores principales: | Yu, Daowu, Liu, Shengwei, Chen, Yijun, Yang, Lumeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322798/ https://www.ncbi.nlm.nih.gov/pubmed/35903365 http://dx.doi.org/10.3389/fgene.2022.944259 |
Ejemplares similares
-
Pan-Cancer Bioinformatics Analysis of Gene UBE2C
por: Yuan, Lin, et al.
Publicado: (2022) -
Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes
por: Feng, Chao, et al.
Publicado: (2021) -
A Case of Male Breast Cancer Patient with CHEK2*1100delC Mutation
por: Nguyen, Quan D, et al.
Publicado: (2020) -
Bioinformatic analysis reveals lysosome-related biomarkers and molecular subtypes in preeclampsia: novel insights into the pathogenesis of preeclampsia
por: Chen, Yao, et al.
Publicado: (2023) -
Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)